CDK8-IN-15
CDK8-IN-15 (Compound 46) is a potent CDK8 inhibitors with an IC50 value of 57 nM. It can enhance the thermal stability of CDK8 along with inhibition against NF-κB and have favourable selectivity across the CDK family and tyrosine kinase. Additionally, it also demostrates a positive effect in vitro psoriasis model induced by TNF-α and alleviats the inflammatory response enhancing the expression of Foxp3 and IL-10, which is promising for research of psoriasis diseases[1].
Product Specifications
CAS Number
2988020-03-5
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cdk8-in-15.html
Smiles
O=C(NC1=CC(OC)=C(C2=CC(C=CN3)=C3N=C2)C=C1)N4CCOCC4
Molecular Formula
C19H20N4O3
Molecular Weight
352.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK8
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
3- (2,5-Dimethylmorpholin-4-yl) -N'-hydroxy-3-oxopropanimidamide
3- (2,5-Dimethylmorpholin-4-yl) -N'-hydroxy-3-oxopropanimidamide
